Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness Analysis

BACKGROUND: Genomic tests may improve the stratification of patients to receive new therapies in several disease areas. However, the use of expensive targeted therapies can impact on the cost effectiveness of these tests. This study presents an economic evaluation of genomic testing in chronic lymph...

Descripción completa

Detalles Bibliográficos
Autores principales: Buchanan, James, Wordsworth, Sarah, Clifford, Ruth, Robbe, Pauline, Taylor, Jenny C., Schuh, Anna, Knight, Samantha J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548825/
https://www.ncbi.nlm.nih.gov/pubmed/28762015
http://dx.doi.org/10.1007/s40273-017-0519-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548825/
https://www.ncbi.nlm.nih.gov/pubmed/28762015
http://dx.doi.org/10.1007/s40273-017-0519-z

Ejemplares similares